Dr. Panackal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Rockville Center for Vaccines Research (GSK)
14200 Shady Grove Rd
Rockville, MD 20850
Summary
- I am an infectious diseases physician with a strong clinical, academic, government, and industry background. Being a public health conscientious and strategic thinking clinician, educator, and researcher for over 25 years, I work on antimicrobial resistance countermeasure (e.g., vaccines) clinical development, focused upon immunocompromised hosts - maybe sentinels for infectious disease outbreaks.
Education & Training
- Yale School of MedicineClass of 1996
Certifications & Licensure
- MD State Medical License 2005 - 2021
Publications & Presentations
PubMed
- 51 citationsA Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States.Kieren A. Marr, Yifei Sun, Andrej Spec, Na Lu, Anil A. Panackal
Clinical Infectious Diseases. 2020-01-02 - 110 citationsCerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.Mika Komori, Andrew Blake, Mark C. Greenwood, Yen Chih Lin, Peter Kosa
Annals of Neurology. 2015-07-01 - 96 citationsClinical significance of azole antifungal drug cross-resistance in Candida glabrata.Anil A. Panackal, Jennifer L. Gribskov, Janet F. Staab, Katherine A. Kirby, M. Rinaldi
Journal of Clinical Microbiology. 2006-05-01
External Links
- LinkedInhttps://www.linkedin.com/in/anil-panackal-972746227
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: